Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor. 1989

T Yukawa, and C Kroegel, and P Evans, and T Fukuda, and K F Chung, and P J Barnes
Department of Thoracic Medicine, Brompton Hospital, London, U.K.

We have examined the induction of hypodense eosinophils by platelet-activating factor (PAF), a mediator which may be involved in eosinophil activation in allergic diseases. Guinea-pig eosinophils were incubated with buffer or PAF and applied to continuous Percoll density gradients. Cellular density ranged from 1.0142 to 1.1369 g/ml. Peak eosinophil density in control was 1.0887 +/- 0.0008 g/ml (mean +/- SEM), and 91.1 +/- 1.4% of eosinophils were distributed between 1.0810 and 1.1000 g/ml. Preincubation of eosinophils with PAF(10(-7) M) resulted in a time-dependent and non-cytolytic increase of the number of hypodense eosinophils, with peak densities after incubation for 1 hr and 2 hr of 1.0834 +/- 0.0014 (n = 4, P less than 0.05) and 1.0755 +/- 0.0007 g/ml (n = 6, P less than 0.01), respectively. After incubation for 2 hr, 82.0 +/- 4.9% (n = 6) eosinophils showed a density lower than 1.080 g/ml. Lyso-PAF, the inactive precursor and metabolite of PAF, at a concentration of 10(-7) M had no effect on cell density. The specific PAF receptor antagonist WEB 2086 (10(-6) M) inhibited the PAF-induced density shift by 87.0 +/- 5.3%. Our results demonstrate that a single mediator is able to induce the formation of hypodense eosinophils. We conclude that the appearance of hypodense eosinophils in allergic diseases such as asthma may occur, at least in part, in response to inflammatory mediators which activate these cells.

UI MeSH Term Description Entries
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D002499 Centrifugation, Density Gradient Separation of particles according to density by employing a gradient of varying densities. At equilibrium each particle settles in the gradient at a point equal to its density. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Centrifugations, Density Gradient,Density Gradient Centrifugation,Density Gradient Centrifugations,Gradient Centrifugation, Density,Gradient Centrifugations, Density
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001381 Azepines Seven membered heterocyclic rings containing a NITROGEN atom. Hexamethyleneimines
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

T Yukawa, and C Kroegel, and P Evans, and T Fukuda, and K F Chung, and P J Barnes
December 1991, Lipids,
T Yukawa, and C Kroegel, and P Evans, and T Fukuda, and K F Chung, and P J Barnes
August 1991, The Journal of allergy and clinical immunology,
T Yukawa, and C Kroegel, and P Evans, and T Fukuda, and K F Chung, and P J Barnes
December 1990, Journal of immunology (Baltimore, Md. : 1950),
T Yukawa, and C Kroegel, and P Evans, and T Fukuda, and K F Chung, and P J Barnes
January 1994, International archives of allergy and immunology,
T Yukawa, and C Kroegel, and P Evans, and T Fukuda, and K F Chung, and P J Barnes
October 1996, Clinical and experimental immunology,
T Yukawa, and C Kroegel, and P Evans, and T Fukuda, and K F Chung, and P J Barnes
September 1992, Respiratory medicine,
T Yukawa, and C Kroegel, and P Evans, and T Fukuda, and K F Chung, and P J Barnes
August 1987, Prostaglandins,
T Yukawa, and C Kroegel, and P Evans, and T Fukuda, and K F Chung, and P J Barnes
March 1996, Proceedings of the National Academy of Sciences of the United States of America,
T Yukawa, and C Kroegel, and P Evans, and T Fukuda, and K F Chung, and P J Barnes
January 1992, American journal of respiratory cell and molecular biology,
T Yukawa, and C Kroegel, and P Evans, and T Fukuda, and K F Chung, and P J Barnes
January 1989, Allergy proceedings : the official journal of regional and state allergy societies,
Copied contents to your clipboard!